Tissue factor pathway inhibitor with high anticoagulant activity is increased in postheparin plasma and in plasma from cancer patients - Lindahl, A K; Jacobsen, P B; Sandset, P M; Abildgaard, U (Blood Coagulation Fibrinolysis, 1991)